Embryonic stem cells are so 2004. The use of adult stem cells have come so far in the last ten years that the “need” for embryonic cells has dropped dramatically.
Nevertheless, a Market Watch article about this states: "ViaCyte's lead product candidate, the VC-01 combination product, is based on the production of pancreatic progenitor cells derived from human pluripotent stem cells." link
My youngest son has Type 1 diabetes, which, should this ever become an actual treatment, presents us with quite the moral dilemma.
For awhile there was a constant drumbeat from the liberals about ESRC, but now we hear nothing. That’s probably because of advancements in using adult stem cells.